John Priestland

If UAP disclosure doesn't happen,

Then there are other things, for example, the rise of artificial general intelligence or who knows what else.

And that's important because our key stakeholder group is governments, public governments, governments, health providers, professional bodies and others for whom the things we're talking about in this podcast, they wouldn't know one end of a three letter acronym from another three letter acronym.

And we have to avoid that, so to speak, sort of tissue rejection.

And if we can frame what we're doing as more general resilience building, that goes down well.

It starts to get us the conversations we need.

The organizations we need to build that resilience exist.

The challenge is getting in front of them and making this topic something they're comfortable with.

And we're back to our old friend stigma, which prevents that.

We started with

research of public health principles and I'll give you a couple briefly.

There's a famous public health practitioner called Jeffrey Rose and his argument is that if a large number of people are exposed to a small risk that produces more harm than a small number of people exposed to a large risk and what comes out of that is you need to try to reduce

the average risk, the average exposure.

And that's what we do with vaccination programs.

And you also need to be able to deal with the people who are affected at some sort of surge capacity.

That was why we needed the nightingale hospitals.

And the second principle is one that the people who are always most affected in disasters and from a public health perspective are those who are most vulnerable.

They've got other challenges, maybe existing mental health conditions, poor socioeconomic background.

And so public health programs need to be designed with that principle in mind that we need to go out of our way to care and support the most vulnerable.

So those are two public health principles that we can apply to disclosure.